Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
This proposal is designed to develop and test several new approaches to the
total synthesis of a wide variety of medicinally active natural products.
The target molecules vary greatly in their structural complexity, ranging
from the complex polycyclic alkaloids (morphine, codeine, reserpine,
piperazinomycin, deosybouvardin and herquline and terpenes (cortisone,
estrone, plaunol C, ajugarins) and lignans (desmethyl epipodophyllotoxin)
to the macrocycle invermectin. The key step of nearly all of the synthetic
approaches is an intramolecular reaction or rearrangement which requires,
by the intramolecularity of the process, the formation of the
stereochemistry desired isomer in preference to all others. The
intramolecular processes used in these syntheses are Diels-Alder reactions,
(3,3)-signatropic shifts, and nucleophilic additions (Michael additions or
additions to immonium salts). In all cases, the syntheses are designed so
as to be quite short (8 steps to morphine, 7 steps to estrone, etc.) and
general enough so that many other structurally related systems could be
formed quite easily. The principles developed in these syntheses - e.g.,
formation of quaternery centers via signmatropic rearrangements, steric
control of the stereochemistry of internal cycloadditions, new protection
sequence for amino acids, among others - would be applicable and of great
value to organic synthesis in general. Because of the extreme shortness of
the syntheses, the importance of the targets, and the high intrinsic value
of the methods themselves, the likelihood of an important contribution to
dhemistry is quite high.
No Sub Projects information available for 5R01GM031349-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM031349-06
Patents
No Patents information available for 5R01GM031349-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM031349-06
Clinical Studies
No Clinical Studies information available for 5R01GM031349-06
News and More
Related News Releases
No news release information available for 5R01GM031349-06
History
No Historical information available for 5R01GM031349-06
Similar Projects
No Similar Projects information available for 5R01GM031349-06